These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 33332679

  • 1. Adult-onset still's disease and treatment results with tocilizumab.
    Kır S, Özgen M, Zontul S.
    Int J Clin Pract; 2021 Mar; 75(3):e13936. PubMed ID: 33332679
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effectiveness of tocilizumab in treating refractory adult-onset Still's disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response.
    Tang KT, Hsieh CW, Chen HH, Chen YM, Chang SH, Huang PH, Lan JL, Chen DY.
    Clin Rheumatol; 2022 Feb; 41(2):557-566. PubMed ID: 34535869
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.
    Cipriani P, Ruscitti P, Carubbi F, Pantano I, Liakouli V, Berardicurti O, Giacomelli R.
    Clin Rheumatol; 2014 Jan; 33(1):49-55. PubMed ID: 24005839
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry.
    Sota J, Vitale A, Lopalco G, Pereira RMR, Giordano HF, Antonelli IPB, Makowska J, Brzezińska O, Lewandowska-Polak A, Ruscitti P, Cipriani P, Cola ID, Govoni M, Ruffili F, Sfikakis PP, Laskari K, Ragab G, Hussein MA, Gentileschi S, Gaggiano C, La Torre F, Maier A, Emmi G, Marino A, Ciccia F, Sfriso P, Maggio MC, Bartoloni E, Lomater C, Hegazy MT, Tektonidou M, Dagostin MA, Opinc A, Sebastiani GD, Giacomelli R, Giudice ED, Olivieri AN, Tufan A, Kardas RK, Nuzzolese R, Cardinale F, Więsik-Szewczyk E, Veronica P, Tarsia M, Iannone F, Della Casa F, Fabiani C, Frediani B, Balistreri A, Rigante D, Cantarini L.
    Semin Arthritis Rheum; 2022 Dec; 57():152089. PubMed ID: 36063578
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
    Suzuki S, Kataoka Y, Otani T, Taniguchi Y, Ikeda K, Tamura N, Morimoto S.
    Clin Rheumatol; 2024 Mar; 43(3):1245-1251. PubMed ID: 38342797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study.
    Nishina N, Kaneko Y, Kameda H, Takeuchi T.
    Mod Rheumatol; 2015 May; 25(3):401-4. PubMed ID: 25401229
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
    Park EH, Lee EY, Shin K, Kim HA.
    Rheumatol Int; 2020 May; 40(5):791-798. PubMed ID: 31598752
    [Abstract] [Full Text] [Related]

  • 17. Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab.
    Imaizumi C, Saito M, Abe F, Kaga H, Saito A, Nara M, Kameyama S, Miura H, Ogasawara H, Hirakawa T, Mizunuma M, Satoh M, Komatsuda A, Terada Y, Takahashi N.
    Intern Med; 2022 Oct 15; 61(20):3137-3140. PubMed ID: 35283384
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of subcutaneous tocilizumab in refractory adult Still's disease: report of three cases and a review of the literature.
    Torigoe M, Maeshima K, Kuriyama Y, Abe I, Ozaki T, Omura Y, Umeki T, Imada C, Ishii K, Shibata H.
    Mod Rheumatol Case Rep; 2021 Jul 15; 5(2):365-370. PubMed ID: 33560182
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.